XML 36 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)
 9 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Selected Information by Business Segment
Selected information by business segment is presented below:
 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 31,
2016
 
December 26,
2015
 
December 31,
2016
 
December 26,
2015
Net revenues
 
 
 
 
 
 
 
Japan
$
20,173

 
$
22,709

 
$
53,730

 
$
60,212

EMEA
49,857

 
53,258

 
141,531

 
150,267

North America Plasma
83,324

 
73,378

 
235,091

 
206,427

All Other
79,884

 
85,218

 
236,315

 
248,217

Net revenues before foreign exchange impact
233,238

 
234,563

 
666,667

 
665,123

Effect of exchange rates
(5,397
)
 
(1,179
)
 
(8,617
)
 
1,367

Net revenues
$
227,841

 
$
233,384

 
$
658,050

 
$
666,490

 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 31,
2016
 
December 26,
2015
 
December 31,
2016
 
December 26,
2015
Segment operating income
 
 
 
 
 
 
 
Japan
$
9,331

 
$
10,013

 
$
24,335

 
$
26,643

EMEA
13,116

 
13,280

 
33,866

 
35,292

North America Plasma
24,660

 
28,445

 
80,209

 
81,909

All Other
26,441

 
29,682

 
82,406

 
88,156

Segment operating income
73,548

 
81,420

 
220,816

 
232,000

  Corporate operating expenses
(38,683
)
 
(46,481
)
 
(132,550
)
 
(142,007
)
  Effect of exchange rates
(151
)
 
(7
)
 
(790
)
 
3,875

Restructuring and turnaround costs
(6,762
)
 
(8,570
)
 
(27,215
)
 
(29,746
)
Deal amortization
(6,530
)
 
(7,389
)
 
(20,611
)
 
(22,193
)
Asset impairments
(210
)
 
(85,048
)
 
(1,525
)
 
(85,048
)
  Contingent consideration income
—

 
4,898

 
—

 
4,727

Operating income
$
21,212

 
$
(61,177
)
 
$
38,125

 
$
(38,392
)
Schedule of Revenues by Product Line and Geographic Regions
Net revenues by franchise are as follows:
 
 
Three Months Ended
Nine Months Ended
(In thousands)
 
December 31,
2016
 
December 26,
2015
 
December 31, 2016
 
December 26, 2015
Plasma
 
$
108,655

 
$
100,578

 
$
309,868

 
$
282,141

Blood Center
 
76,354

 
90,418

 
221,567

 
257,736

Cell Processing
 
25,918

 
27,741

 
77,949

 
83,659

Hemostasis Management
 
16,914

 
14,647

 
48,666

 
42,954

Net revenues
 
$
227,841

 
$
233,384

 
$
658,050

 
$
666,490

Net revenues generated in our principle operating regions on a reported basis are as follows:
 
Three Months Ended
 
Nine Months Ended
(In thousands)
December 31,
2016
 
December 26,
2015
 
December 31,
2016
 
December 26,
2015
United States
$
136,759

 
$
131,664

 
$
393,302

 
$
379,390

Japan
22,319

 
19,482

 
58,949

 
50,406

Europe
38,892

 
52,453

 
116,865

 
150,610

Asia
27,749

 
27,755

 
83,125

 
79,878

Other
2,122

 
2,030

 
5,809

 
6,206

Net revenues
$
227,841

 
$
233,384

 
$
658,050

 
$
666,490